A Trial of Degarelix in Patients With Prostate Cancer
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of
degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in
patients with prostate cancer.